Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Treatment of Acne Vulgaris With Radiofrequency Device

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00441805
Recruitment Status : Withdrawn (Terminated- the study was not started (per Investigator's/sponsor decision))
First Posted : March 1, 2007
Last Update Posted : October 9, 2020
Sponsor:
Information provided by (Responsible Party):
Alma Lasers

Brief Summary:

Radiofrequency emmitting device, normaly used for thermage treatments will be used on 22 mild to moderate acne patients faces.

The aim of the study is to check whether RF heating of subcutaneous and dermis will improve acne in needed patients.


Condition or disease Intervention/treatment Phase
Acne Vulgaris Device: Radio Frequency Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Treatment of Acne Vulgaris With Radiofrequency Device
Estimated Study Start Date : November 2006
Estimated Primary Completion Date : September 2007
Estimated Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • mild-moderate Acne
  • age over 18
  • otherwise healthy

Exclusion Criteria:

  • age under 18
  • pregnancy
  • systemic acne treatment in the last month
  • local acne treatment in the last month

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00441805


Locations
Layout table for location information
Israel
Lase Ohr clinic
Jerusalem, Israel
Sponsors and Collaborators
Alma Lasers
Investigators
Layout table for investigator information
Study Director: Yussi Levcelter, Dr. Alma Lasers LTD
Layout table for additonal information
Responsible Party: Alma Lasers
ClinicalTrials.gov Identifier: NCT00441805    
Other Study ID Numbers: AL-RF/ACN02/06IL CTIL
First Posted: March 1, 2007    Key Record Dates
Last Update Posted: October 9, 2020
Last Verified: October 2020
Keywords provided by Alma Lasers:
Acne
RadioFrequency
Additional relevant MeSH terms:
Layout table for MeSH terms
Acne Vulgaris
Acneiform Eruptions
Skin Diseases
Sebaceous Gland Diseases